Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-19
1998-09-22
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546123, C07D47102, A61K 31435
Patent
active
058114335
ABSTRACT:
The invention relates to novel 1,6-naphthyridonecarboxylic acid derivatives, to processes for their preparation, to antibacterial compositions and feed additives in which they are present, and to novel intermediates for the preparation of these active compounds.
REFERENCES:
patent: 3637716 (1972-01-01), Bimber et al.
patent: 4017622 (1977-04-01), Minami et al.
patent: 4670444 (1987-06-01), Grohe et al.
patent: 5464796 (1995-11-01), Petersen et al.
P. Sanchez et al., J. Heterocyclic Chem., vol. 30, pp. 855-859 (1993).
P. Strehlke, Eur. J. Med. Chem., vol. 12, No. 6 pp. 541-547 (1977).
Chemical Abstracts, vol. 90, abstract No. 103851r, p. 583 abstract of USSR 638, 595 (1979).
Houben-Weyl, Methoden der Org. Chemie, vol. E4, p. 144 (1983).
J.F.W. McOmie, Protective Groups in Organic Chemistry (1973), p. 43.
Bartel Stephan
Bremm Klaus-Dieter
Endermann Rainer
Grohe Klaus
Hagemann Hermann
Bayer Aktiengesellschaft
Grumbling Matthew V.
LandOfFree
1,6-naphthyridonecarboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,6-naphthyridonecarboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,6-naphthyridonecarboxylic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1622040